Skip to main content
All lobbying filings

TODD STRATEGY GROUP

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · ​Biopharmaceutical Company.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $80,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 1
 Lobbying activity 2
Health Issues

Pediatric Priority Review Voucher Program. General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Global supply chain and investment issues. Prescription drug pricing policy.

Medicare/Medicaid

340B Program. Home Infusion for Part B Products. S.864: HELP Copays Act. Medicare Reimbursement for New Technologies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem